CD19 Polyclonal Antibody, Biotin Conjugated
Product Specifications
Background
Assembles with the antigen receptor of B-lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.
Synonyms
Antibody deficiency due to defect in CD19, included; AW495831; B lymphocyte antigen CD19; B lymphocyte surface antigen B4; B4; CD 19; CD19 antigen; CD19 molecule; Cd19 protein; Differentiation Antigen CD19; Leu 12; Leu12; Lymphocyte Surface Antigen; MGC109570; MGC12802; T-cell surface antigen Leu-12
Gene ID
930
Swiss Prot
P15391
Cellular Locus
Cell membrane
Host
Rabbit
Cross Reactivity
Human, Mouse
Immunogen
431-500/556
Target
CD19
Clonality
Polyclonal
Isotype
IgG
Conjugation
Biotin
Source
KLH conjugated synthetic peptide derived from human CD19
Applications
WB, ELISA, IHC-P
Purification
Purified by Protein A.
Concentration
1µg/µl
Dilution
WB (1:300-5000), ELISA (1:500-1000), IHC-P (1:200-400)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C for 12 months.
Gene ID URL
930
Predicted Cross Reactivity
Rat, Cow, Sheep, Pig, Horse, Rabbit
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC941138-500 1x 500 µL
WT1 (Wilm's Tumor 1) (WT1/857 + 6F-H2), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TP309099M 100 µg
C7orf59 (LAMTOR4) (NM_001008395) Human Recombinant Protein
Sign In for Pricing
View Details